Immucell Corp /DE/ SEC filings ICCC
Immucell Corp /DE/ has 795 filings in SEC EDGAR's recent list, going back to Aug 3, 1995. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 5, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2024 | — |
| NT 10-Q | Notification of late filing | Nov 10, 2022 | Sep 30, 2022 |
| DEFR14A | Definitive proxy statement | May 10, 2019 | — |
| EFFECT | Filing | Nov 29, 2018 | — |
| CORRESP | Letter to the SEC | Nov 28, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2018 | — |
| EFFECT | Filing | Dec 14, 2016 | — |
| CORRESP | Letter to the SEC | Dec 14, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2016 | — |
| D | Filing | Oct 24, 2016 | — |
| EFFECT | Filing | Nov 10, 2015 | — |
| CORRESP | Letter to the SEC | Nov 9, 2015 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2013 | — |
| CORRESP | Letter to the SEC | Dec 21, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 11, 2012 | — |
| CT ORDER | Filing | Nov 5, 2010 | — |
| 8-A12B/A | Amendment no.1 to form 8-a | Jul 1, 2008 | — |
| 10KSB | Form 10-ksb | Mar 26, 2008 | Dec 31, 2007 |
| 10QSB | Form 10-qsb | Nov 7, 2007 | Sep 30, 2007 |
| 10QSB | Form 10-qsb | Aug 10, 2007 | Jun 30, 2007 |
| 10QSB | Form 10-qsb | May 14, 2007 | Mar 31, 2007 |
| 10KSB | Form 10-ksb | Mar 28, 2007 | Dec 31, 2006 |
| 10QSB | Form 10-qsb | Nov 13, 2006 | Sep 30, 2006 |
| 10QSB | Form 10-qsb | Aug 7, 2006 | Jun 30, 2006 |
| 10QSB | Form 10-qsb | May 12, 2006 | Mar 31, 2006 |
| UPLOAD | Letter from the SEC | Jul 19, 2005 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2005 | — |
| CORRESP | Letter to the SEC | Jul 8, 2005 | — |
| CORRESP | Letter to the SEC | Jun 16, 2005 | — |
| 10-K405 | Immucell corporation form 10-k for 12/31/2001 | Mar 29, 2002 | Dec 31, 2001 |
| 8-A12B | Filing | Sep 13, 1995 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- ICCC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Portland, ME
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 811641
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.